Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|January 13, 2022
Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogsPrem Kumar Kushwaha, Kumar Saurabh Srivastava, Neha Kumari, et al.Nucleic Acids Research|June 12, 2003
Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regionsShravanti Rampalli, Asavari Kulkarni, Pavan Kumar, et al.Bioorganic & Medicinal Chemistry|April 13, 2010
Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studiesVidya Pawar, Deepak Lokwani, Shashikant Bhandari, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 18, 2012
Emergence of a unique recombinant form of HIV-1 from Manipur (India)Roni Sarkar, Kamalesh Sarkar, N Brajachand Singh, et al.Current HIV/AIDS Reports|January 23, 2020
Recent Advances in the Development of Integrase Inhibitors for HIV TreatmentJay Trivedi, Dinesh Mahajan, Russell J Jaffe, et al.European Journal of Medicinal Chemistry|September 28, 2019
Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activityJay Trivedi, Afsana Parveen, Farhana Rozy, et al.Journal of Medicinal Chemistry|April 14, 2006
Amino functionalized novel cholic acid derivatives induce HIV-1 replication and syncytia formation in T cellsDeepak B Salunke, Dyavar S Ravi, Vandana S Pore, et al.Environmental Pollution (Barking, Essex : 1987)|November 18, 2019
Black carbon aerosol quantification over north-west Himalayas: Seasonal heterogeneity, source apportionment and radiative forcingYogesh Kant, Darga Saheb Shaik, Debashis Mitra, et al.Biochemical and Biophysical Research Communications|March 2, 2005
HIV-1 Tat modulates T-bet expression and induces Th1 type of immune responseAsavari Kulkarni, Dyavar S Ravi, Kamini Singh, et al.The Journal of Biological Chemistry|February 11, 2017
Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryTracy Augustine, Priyanka Chaudhary, Kailash Gupta, et al.Pageof 8